Table 2.
Main adverse events after transplant in the two study groups.
| Patients (n = 25) | Reference-patients (n = 50) | |
|---|---|---|
| Acute rejections—n (%) | 1 (4.0)* | 13 (26.0) |
| DGF—n (%) | 1 (4.0) | 5 (10.0) |
| N. of dialyses | 2 | 1 (1-2) |
| Leukopenia—n (%) | 4 (16) | 8 (16) |
| Thrombocytopenia—n (%) | 0 | 1 (2) |
| CMV reactivations—n (%) | 5 (20)* | 27 (54.0) |
| CMV DNA | 5/25 (20) | 8/14 (57.1) |
| Ag PP65 | — | 19/36 (52.7) |
Data are number (percentage) or median (range). DGF: delayed graft function, leukopenia: leukocytes < 3000/mm3, thrombocytopenia: platelets < 50,000/mm3, *P < 0.05 versus reference-patients.